pathology. To refresh the imaging data, patient can be moved from ISS to MC suites, data acquisition takes place, and the patient is then returned to the ISS where the new MR imaging data can be used to complete the procedure. Results: The current set up also permits utilisation of PET in conjunction with ISS procedures, e.g., as the final imaging modality to control whether PET-enhancing pathology was completely removed or angioplasty perfoemd. For instance, after completion of ablation under MR imaging, the patient can be moved into the PET/CT suite. A PET image produced after tracer injection and uptake can then be used to assess the completeness of the ablation procedure. Conclusions: A room layout combining 3T MRI and PET/CT with other interventional modalities (e.g., fluoroscopy, ultrasound, CT) has been realized for integrated multimodality image-guided diagnosis and therapy of cardiovascular diseases. Such a design enables corollary studies into novel workflows for taking full advantage of the integrated design.
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Background: Diabetes is associated with a higher risk of adverse events following PCI with drug eluting stents (DES). Within the TWENTE trial, a randomized trial comparing zotarolimus-eluting Resolute and everolimus-eluting Xience V stents, a significant interaction was seen between diabetes and DES type with regard to target vessel failure (TVF). In diabetics, safety and efficacy data of these DES are scarce. Methods: In this post-hoc analysis of TWENTE, clinical outcome of both DES in diabetic (nϭ301; 36.2% insulin-treated) and non-diabetic patients (nϭ1090) was compared. Clinical endpoints were adjudicated by an independent, external events committee. Multivariate logistic regression analyses were performed to adjust for differences in baseline variables. Results: Groups stratified by DES were similar except for a higher prevalence of hypercholesterolemia in non-diabetic patients of the Xience V arm (pϭ0.04) and calcified target lesions in diabetic patients of the Resolute arm (pϭ0.04). In both diabetics and non-diabetic patients, multivariate analysis indicated no significant difference in clinical outcome between DES. Within non-insulin-treated diabetics, there was also no significant between-stent difference in clinical outcome. However, in insulin-treated diabetics, the Resolute arm showed higher rates of target vessel failure (TVF)(28.3% vs 7.3%, pϭ0.015), target-lesion failure(26.4% vs. 5.5%, pϭ0.016), and patient oriented composite endpoint(32.1% vs. 10.9%, pϭ0.02). A significant interaction was observed between insulin treatment and DES type for TVF (pϭ0.029). In Resolute treated patients, insulin-treated diabetics had a higher rate of TVF compared to non-diabetics and non-insulin-treated diabetics (pϽ0.001). In the Xience V arm, rates of TVF were similar across all subgroups. Conclusions: In non-diabetic patients and non-insulin-treated diabetics, Resolute and Xience V showed no significant difference in safety and efficacy up to 12 months. In the limited number of insulin-treated diabetics, Resolute was associated with inferior clinical outcome. This hypothesis-generating finding requires confirmation in large randomized trials.
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Meta-analysis of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients with Diabetes and Left Main and/or Multivessel Coronary Artery Disease
Yu Jie Zhou 1 , Fei Gao 2 , Zhijian Wang 2 1 An Zhen Hospital, Capital Medical University, Beijing, China, Beijing, China, 2 Anzhen Hospital affiliated with Capital Medical University, Beijing, Beijing Background: The optimal coronary revascularization strategy for patients with diabetes and left main and/or multivessel disease is undetermined. The aim of our study was to evaluate percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) in those patients. Methods: We identified 13 articles, published before Oct 2011, enrolling 6992 patients, follow-up period ranged from 1 to 5 years. Results: Patients with PCI had a significant reduction in cerebral vascular attack (CVA) (OR 0.29, 95% CI 0.16 to 0.51, pϽ0.0001, I2 ϭ0%) as compared with CABG, whereas there was a four-fold increased risk of repeat revascularization associated with PCI even using drug-eluting stent (OR 4.44, 95% CI 3.42 to 5.78, chi2 ϭ4.92, pϽ0.00001, I2 ϭ0%). The overall mortality (OR 0.97, 95% CI 0.81 to 1.15, pϭ0.70, I2 ϭ0%) was comparable between the PCI and CABG. However, in subgroup analysis, the composite outcome (death/myocardial infarction/CVA) was significantly reduced in TUESDAY, OCTOBER 23, 8:00 AM-10:00 AM 
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